Ukrainian poultry farming is simultaneously going through the challenges of war and showing potential for growth. According to the KSE (Agricultural Outlook Ukraine) forecast, by 2033 poultry meat production may reach 1.7 million tons (+28% compared to 2023), and consumption may increase to 32.3 kg/person/year (+16%). In 2024, poultry meat exports amounted to $962.7 million (+20.4% y/y). Against this background, quality, safety and the rejection of prophylactic antibiotics become decisive - areas where Enzym Group strengthens the market with its biotechnological solutions.
Market: growing demand despite infrastructure losses
The war caused serious losses (estimated destroyed assets - $10.3 billion), in particular in egg production.
In 2024, the decrease in feed costs reduced the cost of chicken to $0.71/kg (–$0.04). Against the backdrop of devaluation, the export attractiveness of products is increasing.
The industry is expected to grow by ~1.1% annually until it returns to pre-crisis levels in 2033.
Trend 1: Feed safety and the rejection of antibiotics
The excessive and prophylactic use of antibiotics no longer meets the requirements of the EU, Middle East and Southeast Asian markets. Europe has already shown: reducing the use of antibiotics in livestock by half is a matter of standards and affordable alternatives.
Enzym Group responds to this demand with natural feeding tools that reduce the need for antibiotics and enhance health and productivity indicators.
Trend 2: Environmental friendliness and transparency of origin
Consumers expect a lower carbon footprint, chain transparency and welfare-oriented housing models. Poultry as a protein with a lower environmental impact is strengthening its position in diets - and this is creating demand for "clean" feeds with proven effectiveness.
Trend 3: Feeding technologies and microbiome solutions
The world is moving towards probiotics, postbiotics, phytogenic substances, enzymes, organic acids, alternative proteins (yeast, fermented proteins, insects for young animals), as well as microencapsulation technologies and heat-stable forms of ingredients that retain activity after granulation.
From farm to lab: what Enzym Group offers
Enzym Group is a Ukrainian biotechnology company in Eastern Europe with a full cycle of research and production of yeast solutions for animals and poultry:
Strain approach: we work with promising Saccharomyces cerevisiae and Kluyveromyces marxianus with proven probiotic potential.
Evidence: from microbiological screening and laboratory studies to animal testing (growth, health status, immune markers, economics).
Production standards: processes comply with HACCP and GMP+; free of antibiotics, chemical preservatives and GMOs.
Enzym Group product lines for poultry:
Live yeast probiotics - support the microbiome, suppress pathogens, improve feed conversion.
Inactivated yeast, hydrolysates, cell wall fractions - natural bioactive complexes for immune modulation and intestinal barrier function.
Combined formulas with enzymes and phytogenic components - for all feeding goals and ages of poultry (broilers, layers).
New: Ukrainian yeast probiotic for broilers
Enzym Group has presented its own innovative yeast-based probiotic for broiler farming - a solution that allows you to partially or completely abandon prophylactic antibiotics in feeding programs.
The approach is complemented by inactivated yeast, hydrolysates and cell walls - for a controlled immune response, stable productivity and improved feed conversion.
Sales geography and compliance with market demands
Foreign markets (EU, MENA, Southeast Asia) are raising the bar for "clean label" and demonstrable effect. Enzym Group's portfolio meets these requirements: natural origin, safe composition, scientifically proven results and adaptation to customers' production tasks.
Competition in poultry farming is intensifying - the world is moving from volumes to quality, safety and sustainability. Enzym Group helps Ukrainian producers meet these demands with natural yeast solutions that:
- support poultry health and productivity,
- reduce antibiotic dependency,
- improve feed economics,
- align local production requirements with global market expectations.
Enzym Group continues to invest in biotechnology to ensure Ukrainian farms stay on course for high-quality, safe, and competitive products — today and in the long term.
